Literature DB >> 30876951

Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention.

Burcin Yavuz1, Jessica L Morgan2, Carolina Herrera3, Kristin Harrington1, Bernardo Perez-Ramirez4, Patricia J LiWang5, David L Kaplan6.   

Abstract

With almost 2 million new HIV infections worldwide each year, the prevention of HIV infection is critical for stopping the pandemic. The only approved form of pre-exposure prophylaxis is a costly daily pill, and it is recognized that several options will be needed to provide protection to the various affected communities around the world. In particular, many at-risk people would benefit from a prevention method that is simple to use and does not require medical intervention or a strict daily regimen. We show that silk fibroin protein can be formulated into insertable discs that encapsulate either an antibody (IgG) or the potent HIV inhibitor 5P12-RANTES. Several formulations were studied, including silk layering, water vapor annealing and methanol treatment to stabilize the protein cargo and impact the release kinetics over weeks. In the case of IgG, high concentrations were released over a short time using methanol treatment, with more sustained results with the use of water vapor annealing and layering during device fabrication. For 5P12-RANTES, sustained release was obtained for 31 days using water vapor annealing. Further, we show that the released inhibitor 5P12-RANTES was functional both in vitro and in ex vivo colorectal tissue. This work shows that silk fibroin discs can be developed into formidable tools to prevent HIV infection.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5P12-RANTES; Broadly neutralizing antibody; Controlled release; HIV microbicide; HIV prevention; Silk fibroin

Year:  2019        PMID: 30876951      PMCID: PMC6538278          DOI: 10.1016/j.jconrel.2019.03.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  59 in total

1.  Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.

Authors:  C A Derdeyn; J M Decker; J N Sfakianos; X Wu; W A O'Brien; L Ratner; J C Kappes; G M Shaw; E Hunter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission.

Authors:  Edward J Fuchs; Linda A Lee; Michael S Torbenson; Teresa L Parsons; Rahul P Bakshi; Anita M Guidos; Richard L Wahl; Craig W Hendrix
Journal:  J Infect Dis       Date:  2007-01-23       Impact factor: 5.226

3.  Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.

Authors:  P Emau; B Tian; B R O'keefe; T Mori; J B McMahon; K E Palmer; Y Jiang; G Bekele; C C Tsai
Journal:  J Med Primatol       Date:  2007-08       Impact factor: 0.667

Review 4.  The use of mucoadhesive polymers in vaginal delivery.

Authors:  Claudia Valenta
Journal:  Adv Drug Deliv Rev       Date:  2005-09-22       Impact factor: 15.470

5.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells.

Authors:  Lorenz Uebersax; Hans P Merkle; Lorenz Meinel
Journal:  J Control Release       Date:  2007-11-17       Impact factor: 9.776

7.  Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.

Authors:  Y Li; H Hui; C J Burgess; R W Price; P M Sharp; B H Hahn; G M Shaw
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy.

Authors:  Zaki Megeed; Mohamed Haider; Daqing Li; Bert W O'Malley; Joseph Cappello; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2004-02-10       Impact factor: 9.776

9.  Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.

Authors:  Y Li; J C Kappes; J A Conway; R W Price; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

10.  Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.

Authors:  Patricia S Fletcher; Julie Elliott; Jean-Charles Grivel; Leonid Margolis; Peter Anton; Ian McGowan; Robin J Shattock
Journal:  AIDS       Date:  2006-06-12       Impact factor: 4.177

View more
  5 in total

Review 1.  Extended release formulations using silk proteins for controlled delivery of therapeutics.

Authors:  Burcin Yavuz; Laura Chambre; David L Kaplan
Journal:  Expert Opin Drug Deliv       Date:  2019-07-01       Impact factor: 6.648

2.  Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.

Authors:  Jordan A Stinson; Archana V Boopathy; Brian M Cieslewicz; Yichen Zhang; Nickolas W Hartman; David P Miller; Matthew Dirckx; Brett L Hurst; E Bart Tarbet; Jonathan A Kluge; Kathryn M Kosuda
Journal:  Vaccine       Date:  2021-08-12       Impact factor: 4.169

3.  Development of a dinutuximab delivery system using silk foams for GD2 targeted neuroblastoma cell death.

Authors:  Kimberly J Ornell; Bill Chiu; Jeannine M Coburn
Journal:  J Biomed Mater Res A       Date:  2020-12-10       Impact factor: 4.854

Review 4.  Silk Fibroin as a Functional Biomaterial for Drug and Gene Delivery.

Authors:  Mhd Anas Tomeh; Roja Hadianamrei; Xiubo Zhao
Journal:  Pharmaceutics       Date:  2019-09-26       Impact factor: 6.321

5.  Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo.

Authors:  Katti R Crakes; Carolina Herrera; Jessica L Morgan; Katie Olstad; Ann J Hessell; Paul Ziprin; Patricia J LiWang; Satya Dandekar
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.